Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenues (2020 revenues net of issuance of Preferred C-1 Shares in the amount of $14,800, see note 2i) $ 6,026 $ 5,466 $ (9,364)
Cost of revenues (14,790) (10,488) (6,407)
Gross loss (8,764) (5,022) (15,771)
Operating expenses:      
Research and development 95,107 93,336 57,029
Sales and marketing 10,300 23,735 5,430
General and administrative 19,178 35,560 3,753
Total operating expenses 124,585 152,631 66,212
Operating loss (133,349) (157,653) (81,983)
Financial income, net 6,802 4,378 655
Loss before taxes on income (126,547) (153,275) (81,328)
Taxes on income (325) (284) (183)
Net loss $ (126,872) $ (153,559) $ (81,511)
Basic net loss per ordinary share $ (0.94) $ (1.54) $ (5.99)
Diluted net loss per ordinary share $ (0.94) $ (1.54) $ (5.99)
Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share 135,224,312 102,859,891 16,514,910